Department of Urology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.
Medicina (Kaunas). 2024 Sep 25;60(10):1573. doi: 10.3390/medicina60101573.
This review discusses recent advances in robotic surgery for urologic tumors, focusing on three key areas: robotic systems, assistive technologies, and artificial intelligence. The Da Vinci SP system has enhanced the minimally invasive nature of robotic surgeries, while the Senhance system offers advantages such as tactile feedback and eye-tracking capabilities. Technologies like 3D reconstruction combined with augmented reality and fluorescence imaging aid surgeons in precisely identifying the anatomical relationships between tumors and surrounding structures, improving surgical efficiency and outcomes. Additionally, the development of artificial intelligence lays the groundwork for automated robotics. As these technologies continue to evolve, we are entering an era of minimally invasive, precise, and intelligent robotic surgery.
这篇综述讨论了泌尿外科肿瘤机器人手术的最新进展,重点关注三个关键领域:机器人系统、辅助技术和人工智能。达芬奇 SP 系统增强了机器人手术的微创性,而 Senhance 系统则提供了触觉反馈和眼动追踪等优势。3D 重建与增强现实和荧光成像等技术相结合,帮助外科医生准确识别肿瘤与周围结构之间的解剖关系,提高手术效率和效果。此外,人工智能的发展为自动化机器人奠定了基础。随着这些技术的不断发展,我们正进入一个微创、精确和智能的机器人手术时代。